Submitted by Anonymous (not verified) on 8 December 2025 - 14:34
Human medicines European public assessment report (EPAR): Filspari, sparsentan, Date of authorisation: 19/04/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Filspari, sparsentan, Date of authorisation: 19/04/2024, Revision: 3, Status: Authorised